Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (1)
Active Filters (1)
Clear All
13 - 24 of 152 Results
Sort by:
Best Match

Integration of next-generation transposon vectors with state-of-the-art host cell lines
Presenting the performance data of CHOSOURCE TnT expressing a standard immunoglobulin G (IgG) molecule with CHOSOURCE CHO-K1 GS KO and ADCC+ cell lines

Webinar. Are you stable or transient? Optimize your biotherapeutic cell line workflows
Hear how Jounce integrated Revvity’s CHOSOURCE GS cell line into their drug development workflow to improve efficiencies

Optimizing biotherapeutic production workflows
See how Elanco have implemented Revvity’s CHOSOURCE GS knockout cell line to help build a biotherapeutics research program in animal health

The evolving landscape of quality by design in biologics manufacturing
Implement QbD principles to meet safety, efficacy, and consistency challenges in biologics manufacturing

CHOSOURCE expression platform
Helping you confront biotherapeutic challenges with a robust CHO expression platform without constraints.

Maximizing returns in biotherapeutic investment: Financial considerations for expression systems
Helping examine the key economic factors when selecting expression systems that impact quality, quantity, and cost-effectiveness for biotherapeutic production.

Ergonomic high-throughput cell counting plates, 8 x 3 orientation
specification sheet for Ergonomic high-throughput cell counting plates, 8 x 3 orientation

Evaluating the specificity of PD-1 and PD-L1 blocking antibodies using AlphaLISA human and mouse PD-1/PD-L1 binding kits
Find out how the AlphaLISA human/mouse PD-1/PD-L1 binding assays provide a fast, powerful, homogeneous platform for obtain binding potencies from potential novel drug candidates.

Utilization of AlphaLISA technology to accurately detect asthma biomarkers in human serum
In this application note, AlphaLISA technology was used to quantify biomarker levels in serum samples, specifically Human IL-21, IL-33, and TNFα.

Fc-Receptor binding ADCC assays utilizing AlphaLISA technology: Characterization of hIgGs and FcγRIIIa
This application note demonstrates how AlphaLISA assay can be used to determine the binding activity of human IgG Fc fragment to human FcγRIIIa and to study how other antibodies bind to FcγRIIIa.

Bioanalytical methods for biosimilarity assessment
Working in partnership to develop and qualify assays in the support of the biosimilarity assessment data package.

Guidelines for optimization of a cell-labelling method for DELFIA-TRF cytotoxicity assays.
Discover expert guidelines for optimizing cell labeling in DELFIA TRF cytotoxicity assays. Learn how to enhance assay performance, manage spontaneous release, and achieve accurate results with this comprehensive application note.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.